These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 29695018)
1. Compliance on Mandatory Data Reporting in Registered Obstetrics Trials. Checketts JX; Evans MB; Athale AH; Jawhar OM; Wright MR; Bryant K; Vassar M Am J Perinatol; 2018 Oct; 35(12):1192-1196. PubMed ID: 29695018 [TBL] [Abstract][Full Text] [Related]
2. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. Prayle AP; Hurley MN; Smyth AR BMJ; 2012 Jan; 344():d7373. PubMed ID: 22214756 [TBL] [Abstract][Full Text] [Related]
3. Compliance with results reporting at ClinicalTrials.gov. Anderson ML; Chiswell K; Peterson ED; Tasneem A; Topping J; Califf RM N Engl J Med; 2015 Mar; 372(11):1031-9. PubMed ID: 25760355 [TBL] [Abstract][Full Text] [Related]
4. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study. DeVito NJ; Bacon S; Goldacre B Lancet; 2020 Feb; 395(10221):361-369. PubMed ID: 31958402 [TBL] [Abstract][Full Text] [Related]
5. Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov. Law MR; Kawasumi Y; Morgan SG Health Aff (Millwood); 2011 Dec; 30(12):2338-45. PubMed ID: 22147862 [TBL] [Abstract][Full Text] [Related]
6. Research without results: inadequate public reporting of clinical trial results. Gopal RK; Yamashita TE; Prochazka AV Contemp Clin Trials; 2012 May; 33(3):486-91. PubMed ID: 22342449 [TBL] [Abstract][Full Text] [Related]
7. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012. Miller JE; Korn D; Ross JS BMJ Open; 2015 Nov; 5(11):e009758. PubMed ID: 26563214 [TBL] [Abstract][Full Text] [Related]
8. The obstetrical research landscape: a cross-sectional analysis of clinical trials from 2007-2020. Steinberg JR; Weeks BT; Reyes GA; Conway Fitzgerald A; Zhang WY; Lindsay SE; Anderson JN; Chan K; Richardson MT; Magnani CJ; Igbinosa I; Girsen A; El-Sayed YY; Turner BE; Lyell DJ Am J Obstet Gynecol MFM; 2021 Jan; 3(1):100253. PubMed ID: 33043288 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov. Riley IL; Boulware LE; Sun JL; Chiswell K; Que LG; Kraft M; Todd JL; Palmer SM; Anderson ML Clin Trials; 2018 Feb; 15(1):87-94. PubMed ID: 29121787 [TBL] [Abstract][Full Text] [Related]
10. Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States. Lassman SM; Shopshear OM; Jazic I; Ulrich J; Francer J BMJ Open; 2017 Sep; 7(9):e015110. PubMed ID: 28942418 [TBL] [Abstract][Full Text] [Related]
11. Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors. Hirsch L Curr Med Res Opin; 2008 Jun; 24(6):1683-9. PubMed ID: 18462565 [TBL] [Abstract][Full Text] [Related]
12. Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis. Wallach JD; Egilman AC; Dhruva SS; McCarthy ME; Miller JE; Woloshin S; Schwartz LM; Ross JS BMJ; 2018 May; 361():k2031. PubMed ID: 29794072 [TBL] [Abstract][Full Text] [Related]
13. The fate of prospective spine studies registered on www.ClinicalTrials.gov. Ohnmeiss DD Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132 [TBL] [Abstract][Full Text] [Related]
14. Outcome reporting among drug trials registered in ClinicalTrials.gov. Bourgeois FT; Murthy S; Mandl KD Ann Intern Med; 2010 Aug; 153(3):158-66. PubMed ID: 20679560 [TBL] [Abstract][Full Text] [Related]
15. ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials. Schwartz LM; Woloshin S; Zheng E; Tse T; Zarin DA Ann Intern Med; 2016 Sep; 165(6):421-30. PubMed ID: 27294570 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198 [TBL] [Abstract][Full Text] [Related]
17. Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study. Zou CX; Becker JE; Phillips AT; Garritano JM; Krumholz HM; Miller JE; Ross JS Trials; 2018 Oct; 19(1):581. PubMed ID: 30352601 [TBL] [Abstract][Full Text] [Related]
18. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. Ross JS; Mulvey GK; Hines EM; Nissen SE; Krumholz HM PLoS Med; 2009 Sep; 6(9):e1000144. PubMed ID: 19901971 [TBL] [Abstract][Full Text] [Related]
19. An Institutional Program to Increase Compliance with Clinicaltrials.gov Requirements. Kelly-Pumarol I; Andrews JE Ther Innov Regul Sci; 2019 Mar; 53(2):190-192. PubMed ID: 29807449 [TBL] [Abstract][Full Text] [Related]
20. Overview of registered studies in orthodontics: Evaluation of the ClinicalTrials.gov registry. Allareddy V; Rampa S; Masoud MI; Lee MK; Nalliah R; Allareddy V Am J Orthod Dentofacial Orthop; 2014 Nov; 146(5):587-93. PubMed ID: 25439209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]